Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial - PubMed (original) (raw)
Randomized Controlled Trial
doi: 10.1186/1741-7015-11-164.
Mònica Bulló, Miguel Ángel Martínez-González, Emilio Ros, Dolores Corella, Ramon Estruch, Montserrat Fitó, Fernando Arós, Julia Wärnberg, Miquel Fiol, José Lapetra, Ernest Vinyoles, Rosa Maria Lamuela-Raventós, Lluís Serra-Majem, Xavier Pintó, Valentina Ruiz-Gutiérrez, Josep Basora, Jordi Salas-Salvadó; PREDIMED study group
Collaborators, Affiliations
- PMID: 23866098
- PMCID: PMC3738153
- DOI: 10.1186/1741-7015-11-164
Randomized Controlled Trial
Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial
Marta Guasch-Ferré et al. BMC Med. 2013.
Abstract
Background: Prospective studies in non-Mediterranean populations have consistently related increasing nut consumption to lower coronary heart disease mortality. A small protective effect on all-cause and cancer mortality has also been suggested. To examine the association between frequency of nut consumption and mortality in individuals at high cardiovascular risk from Spain, a Mediterranean country with a relatively high average nut intake per person.
Methods: We evaluated 7,216 men and women aged 55 to 80 years randomized to 1 of 3 interventions (Mediterranean diets supplemented with nuts or olive oil and control diet) in the PREDIMED ('PREvención con DIeta MEDiterránea') study. Nut consumption was assessed at baseline and mortality was ascertained by medical records and linkage to the National Death Index. Multivariable-adjusted Cox regression and multivariable analyses with generalized estimating equation models were used to assess the association between yearly repeated measurements of nut consumption and mortality.
Results: During a median follow-up of 4.8 years, 323 total deaths, 81 cardiovascular deaths and 130 cancer deaths occurred. Nut consumption was associated with a significantly reduced risk of all-cause mortality (P for trend<0.05, all). Compared to non-consumers, subjects consuming nuts>3 servings/week (32% of the cohort) had a 39% lower mortality risk (hazard ratio (HR) 0.61; 95% CI 0.45 to 0.83). A similar protective effect against cardiovascular and cancer mortality was observed. Participants allocated to the Mediterranean diet with nuts group who consumed nuts>3 servings/week at baseline had the lowest total mortality risk (HR 0.37; 95% CI 0.22 to 0.66).
Conclusions: Increased frequency of nut consumption was associated with a significantly reduced risk of mortality in a Mediterranean population at high cardiovascular risk.Please see related commentary: http://www.biomedcentral.com/1741-7015/11/165.
Trial registration: Clinicaltrials.gov. International Standard Randomized Controlled Trial Number (ISRCTN): 35739639. Registration date: 5 October 2005.
Figures
Figure 1
Adjusted hazard ratios of total mortality by frequency of nut consumption and intervention group. The Cox regression models were adjusted for age in years, sex, BMI in kg/m2, smoking status (never, former, current smoker), educational level (illiterate/primary education, secondary education, academic/graduate), leisure time physical activity in MET-min/day, history of diabetes (yes/no), history of hypercholesterolemia (yes/no), use of oral antidiabetic medication (yes/no), use of antihypertensive medication (yes/no), use of statins (yes/no), total energy intake (kcal/d), dietary variables in quintiles (vegetables, fruits, red meat, eggs and fish), alcohol intake (continuous, adding a quadratic term), and Mediterranean diet adherence (13-point score). The model was stratified by recruitment centre. Extremes of total energy intake were excluded. Values for the two upper categories of nut consumption are 0.38 (95% CI: 0.23 to 0.63) and 0.37 (95% CI: 0.22 to 0.66) in the Mediterranean diet supplemented with nuts (MedDiet + NUTS) group; 0.79 (95% CI: 0.50 to 1.24) and 0.63 (95% CI: 0.36 to 1.1) in the Mediterranean diet supplemented with extra-virgin olive oil (MedDiet + EVOO) group; and 1.04 (95% CI: 0.64 to 1.69) and 0.84 (95% CI: 0.48 to 1.44) in the low-fat control diet group. P for the interaction between baseline nut consumption and intervention group= 0.019. P for trend: MedDiet + NUTS, p=0.01; MedDiet + EVOO, p=0.15; Control diet, p=0.42.
Comment in
- Should we go nuts about nuts?
Rohrmann S, Faeh D. Rohrmann S, et al. BMC Med. 2013 Jul 16;11:165. doi: 10.1186/1741-7015-11-165. BMC Med. 2013. PMID: 23866107 Free PMC article.
Similar articles
- Olive oil intake and risk of cardiovascular disease and mortality in the PREDIMED Study.
Guasch-Ferré M, Hu FB, Martínez-González MA, Fitó M, Bulló M, Estruch R, Ros E, Corella D, Recondo J, Gómez-Gracia E, Fiol M, Lapetra J, Serra-Majem L, Muñoz MA, Pintó X, Lamuela-Raventós RM, Basora J, Buil-Cosiales P, Sorlí JV, Ruiz-Gutiérrez V, Martínez JA, Salas-Salvadó J. Guasch-Ferré M, et al. BMC Med. 2014 May 13;12:78. doi: 10.1186/1741-7015-12-78. BMC Med. 2014. PMID: 24886626 Free PMC article. Clinical Trial. - Dietary magnesium intake is inversely associated with mortality in adults at high cardiovascular disease risk.
Guasch-Ferré M, Bulló M, Estruch R, Corella D, Martínez-González MA, Ros E, Covas M, Arós F, Gómez-Gracia E, Fiol M, Lapetra J, Muñoz MÁ, Serra-Majem L, Babio N, Pintó X, Lamuela-Raventós RM, Ruiz-Gutiérrez V, Salas-Salvadó J; PREDIMED Study Group. Guasch-Ferré M, et al. J Nutr. 2014 Jan;144(1):55-60. doi: 10.3945/jn.113.183012. Epub 2013 Nov 20. J Nutr. 2014. PMID: 24259558 Clinical Trial. - Extravirgin olive oil consumption reduces risk of atrial fibrillation: the PREDIMED (Prevención con Dieta Mediterránea) trial.
Martínez-González MÁ, Toledo E, Arós F, Fiol M, Corella D, Salas-Salvadó J, Ros E, Covas MI, Fernández-Crehuet J, Lapetra J, Muñoz MA, Fitó M, Serra-Majem L, Pintó X, Lamuela-Raventós RM, Sorlí JV, Babio N, Buil-Cosiales P, Ruiz-Gutierrez V, Estruch R, Alonso A; PREDIMED Investigators. Martínez-González MÁ, et al. Circulation. 2014 Jul 1;130(1):18-26. doi: 10.1161/CIRCULATIONAHA.113.006921. Epub 2014 Apr 30. Circulation. 2014. PMID: 24787471 Clinical Trial. - Mediterranean diet and cardiovascular health: Teachings of the PREDIMED study.
Ros E, Martínez-González MA, Estruch R, Salas-Salvadó J, Fitó M, Martínez JA, Corella D. Ros E, et al. Adv Nutr. 2014 May 14;5(3):330S-6S. doi: 10.3945/an.113.005389. Print 2014 May. Adv Nutr. 2014. PMID: 24829485 Free PMC article. Review. - Nuts and CVD.
Ros E. Ros E. Br J Nutr. 2015 Apr;113 Suppl 2:S111-20. doi: 10.1017/S0007114514003924. Br J Nutr. 2015. PMID: 26148914 Review.
Cited by
- The Mediterranean Diet in Pregnancy: Implications for Maternal Brain Morphometry in a Secondary Analysis of the IMPACT BCN Randomized Clinical Trial.
Nakaki A, Gomez Y, Castro-Barquero S, Conti A, Vellvé K, Casas I, Genero M, Youssef L, Segalés L, Benitez L, Casas R, Vieta E, Bargallo N, Toschi N, Estruch R, Crispi F, Gratacos E, Crovetto F. Nakaki A, et al. Nutrients. 2024 May 24;16(11):1604. doi: 10.3390/nu16111604. Nutrients. 2024. PMID: 38892540 Free PMC article. Clinical Trial. - Mediterranean diet: a potential player in the link between oral microbiome and oral diseases.
Augimeri G, Caparello G, Caputo I, Reda R, Testarelli L, Bonofiglio D. Augimeri G, et al. J Oral Microbiol. 2024 Mar 19;16(1):2329474. doi: 10.1080/20002297.2024.2329474. eCollection 2024. J Oral Microbiol. 2024. PMID: 38510981 Free PMC article. Review. - Weight-centric prevention of cancer.
Anazco D, Acosta A, Cathcart-Rake EJ, D'Andre SD, Hurtado MD. Anazco D, et al. Obes Pillars. 2024 Mar 5;10:100106. doi: 10.1016/j.obpill.2024.100106. eCollection 2024 Jun. Obes Pillars. 2024. PMID: 38495815 Free PMC article. Review. - Consumption of Tree Nuts as Snacks Reduces Metabolic Syndrome Risk in Young Adults: A Randomized Trial.
Sumislawski K, Widmer A, Suro RR, Robles ME, Lillegard K, Olson D, Koethe JR, Silver HJ. Sumislawski K, et al. Nutrients. 2023 Dec 9;15(24):5051. doi: 10.3390/nu15245051. Nutrients. 2023. PMID: 38140310 Free PMC article. Clinical Trial. - Nut consumption and urogenital and genital, gastrointestinal and women-related cancers: Assessment and review.
Mohamadi M, Dousdampanis P, Ahmadi Z, Pourmasumi S, Naderi M, Zainodini N, Nazari A. Mohamadi M, et al. Chronic Dis Transl Med. 2023 Jul 19;9(4):277-287. doi: 10.1002/cdt3.87. eCollection 2023 Dec. Chronic Dis Transl Med. 2023. PMID: 37915385 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources